a year ago
CAPR
AnalystsBoobalan PachaiyappanBoobalan Pachaiyappan's Stock Forecasts
AnalystsBoobalan Pachaiyappan
Sectors:
Industries:
Analyst Ranking
Top 33%
#1811 out of 5550 analysts
Average Return
+1.38%
Win Rate
44%17 out of 39
Risk vs Reward
Poor
Good
Boobalan Pachaiyappan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Capricor Therapeutics IncCAPR | +179.08% | $7.39 | $20.61 | 2025-07-14 - 2026-07-13 | Strong Buy |
Verona Pharma PLCVRNA | +136.53% | $45.20 | $106.91 | 2025-01-10 - 2025-10-07 | Strong Buy |
Capricor Therapeutics IncCAPR | +113.70% | $12.19 | $26.05 | 2025-06-17 - 2026-06-16 | Strong Buy |
Cervomed IncCRVO | +105.93% | $2.36 | $4.86 | 2025-03-11 - 2026-03-10 | Strong Buy |
Gain Therapeutics IncGANX | +104.68% | $1.71 | $3.50 | 2024-12-05 - 2025-12-04 | Strong Buy |
Boobalan Pachaiyappan Analyst Color
Get additional color on Boobalan Pachaiyappan's coverage of popular stocks
2 years ago
CRVO
2 years ago
CRVO
Boobalan Pachaiyappan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Atrium Therapeutics IncRNA | 1 | Strong Buy | $15.00 | +81.38% | Initiates Coverage On | 10 days ago |
Lb Pharmaceuticals IncLBRX | 1 | Hold | $35.00 | -11.84% | Downgrades | a month ago |
Abeona Therapeutics IncABEO | 1 | Strong Buy | $17.00 | +290.80% | Initiates Coverage On | a month ago |
Medicinova IncMNOV | 1 | Strong Buy | $6.00 | +328.57% | Initiates Coverage On | a month ago |
Annovis Bio IncANVS | 2 | Strong Buy | $7.00 | +519.47% | Maintains | 2 months ago |
Coya Therapeutics IncCOYA | 2 | Strong Buy | $12.00 | +232.41% | Reiterates | 2 months ago |
Cingulate IncCING | 6 | Strong Buy | $9.00 | +80.72% | Reiterates | 2 months ago |
Promis Neurosciences IncPMN | 1 | Strong Buy | $19.00 | +474.02% | Initiates Coverage On | 4 months ago |
Reviva Pharmaceuticals Holdings IncRVPH | 3 | Strong Buy | $1.00 | +203.03% | Maintains | 7 months ago |
Cervomed IncCRVO | 5 | Strong Buy | $11.00 | +587.50% | Maintains | 7 months ago |
Neurosense Therapeutics LtdNRSN | 1 | Strong Buy | $60.00 | +2,915.08% | Initiates Coverage On | 8 months ago |
Ovid Therapeutics IncOVID | 1 | Strong Buy | $3.00 | +18.11% | Initiates Coverage On | a year ago |
Polypid LtdPYPD | 3 | Strong Buy | $9.00 | +66.98% | Maintains | a year ago |
Capricor Therapeutics IncCAPR | 3 | Strong Buy | $13.00 | +103.76% | Maintains | a year ago |
Avidity Biosciences IncRNAM | 1 | Strong Buy | $62.00 | N/A | Initiates Coverage On | a year ago |
Longeveron IncLGVN | 2 | Strong Buy | $30.00 | N/A | Maintains | a year ago |
Gain Therapeutics IncGANX | 3 | Strong Buy | $6.00 | N/A | Maintains | a year ago |
Verona Pharma PLCVRNA | 2 | Strong Buy | $116.00 | N/A | Reiterates | a year ago |
Entrada Therapeutics IncTRDA | 1 | Strong Buy | $29.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.